Results 181 to 190 of about 1,315,640 (306)

Impact of China's National Volume‐Based Procurement Policy on Cost, Volume, and Market Structure: An Interrupted Time‐Series Analysis of Montelukast Sodium

Health Care Science, EarlyView.
Using ARIMA‐based interrupted time‐series analysis, this study reveals that China's NVBP policy significantly reduced daily costs and enhanced affordability, driving generic substitution and the elimination of low‐quality products. Additionally, non‐winning manufacturers adopted strategic pricing behaviors to segment the market.
Yufei Cheng, Fanyu Liu, Yongyi Wu, Siyu Liu, Xiaohan Fan, Bin Jiang, Zhao Yang   +6 more
wiley   +1 more source

The Effects of Compulsory Licensing: A Case Study of HIV Drugs

Health Economics, EarlyView.
ABSTRACT Compulsory licensing is a legal mechanism that allows governments the use of patented medicines without the owner's consent, subject to conditions and compensation, to meet public‐health needs. Despite its policy relevance and increasing use, empirical evidence on its market effects remains limited.
Nicolau Martin‐Bassols, Miquel Serra‐Burriel, Kerstin Noelle Vokinger   +2 more
wiley   +1 more source

A hybrid grey wolf optimized eXtreme gradient boosting-based machine learning model for hospital pharmaceutical demand forecasting. [PDF]

Sci Rep
Samniang W, Shah SMT, Tun YM, Munawar A, K C S.   +4 more
europepmc   +1 more source

Healthcare Costs Following Medical Gender‐Affirmation: Evidence From Whole‐of‐Population Australian Administrative Data

Health Economics, EarlyView.
ABSTRACT Gender incongruence in trans and nonbinary (“trans”) populations is often associated with psychological distress and increased demand for mental healthcare. Gender‐affirming hormone therapy (GAHT) is a key component of care for many trans people, yet long‐term evidence around its cost implications remains limited despite increasing uptake and ...
Karinna Saxby, Dennis Petrie, Brendan J. Nolan   +2 more
wiley   +1 more source

TRIPS, pharmaceutical patents, and generic competition in India. [PDF]

Health Aff Sch
Kyle MK, Sampat BN, Shadlen KC.
europepmc   +1 more source

New Medical Schools, Access to Physicians, and Health Outcomes: Evidence From Japan

Health Economics, EarlyView.
ABSTRACT We analyse the impact of the construction of medical schools and associated university hospitals in Japan during the 1970s, which was primarily driven by ‘One Prefecture, One Medical School Policy’ (OPOMS). We find that the number of physicians increased significantly in prefectures where a medical school was built, and this effect persisted ...
Kisho Hoshi
wiley   +1 more source

Correction: Trajectories of kidney function over 10 years in patients with chronic kidney disease: a 10 year follow-up of FROM-J study. [PDF]

Clin Exp Nephrol
Okubo R, Kondo M, Saito C, Kai H, Tsunoda R, Kato A, Maruyama S, Wada J, Wada T, Narita I, Yamagata K.   +10 more
europepmc   +1 more source

What Can Providers' Motivations Tell Us About Healthcare Quality?

Health Economics, EarlyView.
ABSTRACT Agency theory suggests that variation in providers' quality of care may be explained by their heterogeneous motivations. We provide novel empirical evidence on the links between different sources of provider motivation and quality of care by combining a unique 4‐year survey dataset on Danish general practitioners' motivations with quality ...
Lucy Margaret Poole, Line Bjørnskov Pedersen, Anne Sophie Oxholm   +2 more
wiley   +1 more source

Education as an upstream social security intervention: constructing a competency-based talent development framework in health economics. [PDF]

Front Public Health
Luo H, Li A, Hua H.
europepmc   +1 more source

Spatiotemporal evolution and spatial benefit analysis of the coupling coordination of China's three medical systems. [PDF]

Front Public Health
Yue T, Zhu Z, Song Q, Li D, Deng J.
europepmc   +1 more source